Will Urinary Dickkopf-3 Disrupt the Field of Contrast-Induced Acute Kidney Injury?

Competing Interests: Funding Support and Author Disclosures Dr. Gurm has received research support from Blue Cross and Blue Shield of Michigan, and Michigan Translational Research and Commercialization for Life Sciences Innovation Hub; is the co-founder of, owns equity in, and is a consultant to Amplitude Vascular Systems; owns equity in Jiaxing Bossh Medical Technology Partnership; is a consultant for Osprey Medical; and is the chair of the Clinical Events Committee for the PERFORMANCE trial sponsored by Contego Medical.